Back to News
Market Impact: 0.35
Healthcare software firm Waystar explores options including sale, sources say
Source: reuters.com
M&A & RestructuringHealthcare & BiotechFintech

Waystar, a healthcare payments software provider, is exploring strategic options including a potential sale that could take it private roughly two years after its New York stock-market listing. The reported process could affect Waystar’s valuation and shares, but no prospective buyer, transaction value, or timeline was disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
WAY0.15
More News
- Grab aims for 'next level' in financial services with purchase of buy-now pay-later platform Atome
- Exclusive-Malaysia talks to rival airlines as it monitors AirAsia’s financial health, sources say
- Factbox-Private equity, foreign investors fuel Aussie M&A activity in 2026
- Australia’s Reliance Worldwide agrees to Brookfield’s $2.9 billion buyout bid
- Wells Fargo sees improvement in a key metric — plus, Lilly gets praise beyond GLP-1s
- Reliance Worldwide shares hit 1-year high on Brookfield’s $2.9 bln deal